I agree completely I have said before that the neurologist who hears of this is going to feel shock that could be akin to a diagnosis .when the fight or flight reaction is presented to them instead of the patients
beyondms wrote:A buddy of mine who is a cardiologist at Stanford wrote me this:
Can you forward to me the data Zamboni presented regarding treatment of 65 subjects with stenting? Did he treat subjects who were predominantly in the relapsing remitting phase of MS? If he did, then it is difficult to pass judgment on his therapy despite his spectacular results and I would probably not undergo this procedure until a double blind study demonstrates 1) safety and 2) benefit. One must not forget that a blockage in the neck veins due to thrombosis of a stent can cause serious problems. It is much easier for a stent in a vein to clot than a stent in an artery.
The good news is that it looks like the trial is probably easy to do and can be done quickly and there are research dollars set aside for it already in Canada (research competition with deadline end of jan).
As with any new treatment, discuss it with your physician and carefully weigh the pros and cons.
This group included 35 patients with a relapsing-remitting (RR) clinical course, 20 with secondary progressive (SP), and 10 with primary progressive (PP) course.21
Users browsing this forum: ALA